Omeros Shares Rise on Balance Sheet Strengthening

By Colin Kellaher Omeros shares rose sharply Monday after the biopharmaceutical company unveiled a series of financial transactions that bolstered its balance sheet and extended the maturity of a sub

WSJJun 3 11:33 ET

Express News | Omeros Corp: Entered Credit Agreement Which Provides for a Senior Secured Term Loan Facility Initially of up to $92.1 Mln

ReutersJun 3 09:03 ET

Omeros Corporation Further Strengthens Its Balance Sheet Through Series of Financing Transactions Extending Maturity on a Majority of Its Outstanding Debt Into 2028

Omeros Corporation (Nasdaq: OMER) today announced that it has completed a series of strategic financial transactions, further strengthening its balance sheet and extending the maturity profile on a substantial portion of its debt from February 2026 to June 2028, while providing a secure source of capital to support potential commercialization of its lectin pathway inhibitor narsoplimab and flexibility to manage the remaining balance of 2026 convertible notes.

BusinesswireJun 3 09:00 ET

Health Care Flat as Momentum Wanes -- Health Care Roundup

Health-care companies were flat as momentum in the sector stalled. Obesity drug maker Novo Nordisk and Eli Lilly gave back some of their recent gains. Omeros shares tumbled after the clinical-stage b

Dow JonesMay 16 17:35 ET

Why Fluent Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Fluent Inc (NASDAQ:FLNT) fell sharply during Thursday's session after posting weaker-than-expected quarterly results.Fluent posted adjusted loss of 30 cents per share, versus market expectat

BenzingaMay 16 13:06 ET

SYTA, DATS and CYN Among Mid-day Movers

Seeking AlphaMay 16 12:59 ET